These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effects of motivational interviewing-based adherence therapy for schizophrenia spectrum disorders: a randomized controlled trial. Chien WT; Mui JH; Cheung EF; Gray R Trials; 2015 Jun; 16():270. PubMed ID: 26072311 [TBL] [Abstract][Full Text] [Related]
5. Prospective trial of customized adherence enhancement plus long-acting injectable antipsychotic medication in homeless or recently homeless individuals with schizophrenia or schizoaffective disorder. Sajatovic M; Levin J; Ramirez LF; Hahn DY; Tatsuoka C; Bialko CS; Cassidy KA; Fuentes-Casiano E; Williams TD J Clin Psychiatry; 2013 Dec; 74(12):1249-55. PubMed ID: 24434094 [TBL] [Abstract][Full Text] [Related]
6. Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study. Baloush-Kleinman V; Levine SZ; Roe D; Shnitt D; Weizman A; Poyurovsky M Schizophr Res; 2011 Aug; 130(1-3):176-81. PubMed ID: 21636254 [TBL] [Abstract][Full Text] [Related]
7. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists]. Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914 [TBL] [Abstract][Full Text] [Related]
8. Impact of multifamily psychoeducational psychotherapy in treating children aged 8 to 12 years with mood disorders. Fristad MA; Verducci JS; Walters K; Young ME Arch Gen Psychiatry; 2009 Sep; 66(9):1013-21. PubMed ID: 19736358 [TBL] [Abstract][Full Text] [Related]
9. How do socio-demographic and clinical factors interact with adherence attitude profiles in schizophrenia? A cluster-analytical approach. Beck EM; Cavelti M; Wirtz M; Kossowsky J; Vauth R Psychiatry Res; 2011 May; 187(1-2):55-61. PubMed ID: 21074860 [TBL] [Abstract][Full Text] [Related]
10. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals. Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012 [TBL] [Abstract][Full Text] [Related]
11. Interventions to improve medication adherence in schizophrenia. Zygmunt A; Olfson M; Boyer CA; Mechanic D Am J Psychiatry; 2002 Oct; 159(10):1653-64. PubMed ID: 12359668 [TBL] [Abstract][Full Text] [Related]
13. [Relationships between insight and medication adherence in subjects with psychosis]. Droulout T; Liraud F; Verdoux H Encephale; 2003; 29(5):430-7. PubMed ID: 14615692 [TBL] [Abstract][Full Text] [Related]
14. Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. Ascher-Svanum H; Faries DE; Zhu B; Ernst FR; Swartz MS; Swanson JW J Clin Psychiatry; 2006 Mar; 67(3):453-60. PubMed ID: 16649833 [TBL] [Abstract][Full Text] [Related]
15. An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand. Maneesakorn S; Robson D; Gournay K; Gray R J Clin Nurs; 2007 Jul; 16(7):1302-12. PubMed ID: 17584349 [TBL] [Abstract][Full Text] [Related]
16. Psychiatrist and patient responses to suspected medication nonadherence in schizophrenia spectrum disorders. Hamann J; Lipp ML; Christ-Zapp S; Spellmann I; Kissling W Psychiatr Serv; 2014 Jul; 65(7):881-7. PubMed ID: 24686753 [TBL] [Abstract][Full Text] [Related]
17. Are we addressing the 'right stuff' to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication. Beck EM; Cavelti M; Kvrgic S; Kleim B; Vauth R Schizophr Res; 2011 Oct; 132(1):42-9. PubMed ID: 21820875 [TBL] [Abstract][Full Text] [Related]
18. A randomized controlled trial of long-acting injectable risperidone vs continuation on oral atypical antipsychotics for first-episode schizophrenia patients: initial adherence outcome. Weiden PJ; Schooler NR; Weedon JC; Elmouchtari A; Sunakawa A; Goldfinger SM J Clin Psychiatry; 2009 Oct; 70(10):1397-406. PubMed ID: 19906343 [TBL] [Abstract][Full Text] [Related]
19. Impact of early nonadherence to oral antipsychotics on clinical and economic outcomes among patients with schizophrenia. Offord S; Lin J; Mirski D; Wong B Adv Ther; 2013 Mar; 30(3):286-97. PubMed ID: 23483449 [TBL] [Abstract][Full Text] [Related]
20. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP; J Clin Psychiatry; 2009; 70 Suppl 4():1-46; quiz 47-8. PubMed ID: 19686636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]